445
Views
21
CrossRef citations to date
0
Altmetric
Reviews

MicroRNAs (MiRs) Precisely Regulate Immune System Development and Function in Immunosenescence Process

&

REFERENCES

  • Spazzafumo L, Olivieri F, Abbatecola AM, et al. Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr). 2011. Epub 2011/12/17.
  • Cevenini E, Bellavista E, Tieri P, et al. Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies. Curr Pharm Des. 2010;16(7):802–13. Epub 2010/04/15.
  • Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118(1):75–86. Epub 1988/01/01.
  • Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232–6. Epub 2011/11/04.
  • Jiang M, Xiang Y, Wang D, et al. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell. 2012;11(1):29–40. Epub 2011/10/11.
  • Frasca D, Landin AM, Riley RL, Blomberg BB. Mechanisms for decreased function of B cells in aged mice and humans. J Immunol. 2008;180(5):2741–6. Epub 2008/02/23.
  • Van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007;178(2):970–5. Epub 2007/01/05.
  • Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev. 1997;160:55–62. Epub 1998/02/26.
  • Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5(2):133–9. Epub 2004/01/30.
  • Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev. 1997;160:63–77. Epub 1998/02/26.
  • Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand. J Immunol. 2005;175(2):1232–8. Epub 2005/07/09.
  • Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol. 2002;3(1):69–75. Epub 2001/12/18.
  • Bhaumik D, Scott GK, Schokrpur S, et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging. 2009;1(4):402–11. Epub 2010/02/12.
  • O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163–75. Epub 2011/02/19.
  • Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol. 2008;20(2):214–21. Epub 2008/03/11.
  • Aalaei-Andabili SH, Rezaei N. Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) promotes proper immune response against infections: A systematic review. J Infect. 2013;67(4):251–64. Epub 2013/07/16.
  • Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316(5824):608–11. Epub 2007/04/28.
  • Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125–9. Epub 2008/02/19.
  • Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8):5082–9. Epub 2007/10/04.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97. Epub 2004/01/28.
  • Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann New York Acad Sci. 2000;908:244–54. Epub 2000/07/27.
  • Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481–6. Epub 2006/08/04.
  • Ceppi M, Pereira PM, Dunand-Sauthier I, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A. 2009;106(8):2735–40. Epub 2009/02/06.
  • Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511. Epub 2004/07/02.
  • Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208(6):1189–201. Epub 2011/05/11.
  • Zhao JL, Rao DS, Boldin MP, et al. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A. 2011;108(22):9184–9. Epub 2011/05/18.
  • Olivieri F, Lazzarini R, Recchioni R, et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr). 2012. Epub 2012/ 06/14.
  • Rodier F, Coppe JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nature Cell Biol. 2009;11(8):973–9. Epub 2009/07/15.
  • Olivieri F, Procopio AD, Montgomery RR. Effect of aging on microRNAs and regulation of pathogen recognition receptors. Curr Opin Immunol. 2014;29C:29–37. Epub 2014/04/29.
  • Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS biology. 2008;6(12):2853–68. Epub 2008/12/05.
  • Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Resp Crit Care Med. 1999;160(5 Pt 2):S5–11. Epub 1999/11/11.
  • Scapini P, Lapinet-Vera JA, Gasperini S, et al. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000;177:195–203. Epub 2001/01/04.
  • Lysgaard C, Nielsen MS, Christensen JH, et al. No effect of high-dose atorvastatin on leukotriene B(4) formation from neutrophils in patients treated with coronary bypass surgery: a randomized placebo-controlled double-blinded trial with a crossover design. Prostaglandins Leukot Essent Fatty Acids. 2012;87(6):185–8. Epub 2012/10/16.
  • Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980;286(5770):264–5. Epub 1980/07/17.
  • Ward JR, Heath PR, Catto JW, et al. Regulation of neutrophil senescence by microRNAs. PLoS One. 2011;6(1):e15810. Epub 2011/02/02.
  • Martin C, Burdon PC, Bridger G, et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003;19(4):583–93. Epub 2003/10/18.
  • Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res. 2009;43(1–3):25–61. Epub 2008/12/11.
  • Colotta F, Re F, Polentarutti N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80(8):2012–20. Epub 1992/10/15.
  • Whyte MK, Savill J, Meagher LC, et al. Coupling of neutrophil apoptosis to recognition by macrophages: coordinated acceleration by protein synthesis inhibitors. J Leukoc Biol. 1997;62(2):195–202. Epub 1997/08/01.
  • Dorhoi A, Iannaccone M, Farinacci M, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013;123(11):4836–48. Epub 2013/10/03.
  • Haneklaus M, Gerlic M, O'Neill LA, Masters SL. miR-223: infection, inflammation and cancer. J Int Med. 2013;274(3):215–26. Epub 2013/06/19.
  • Tsang WP, Kwok TT. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis : Int J Programmed Cell Death. 2008;13(10):1215–22. Epub 2008/09/02.
  • Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007;26(42):6133–40. Epub 2007/04/04.
  • Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today. 1993;14(11):547–53. Epub 1993/11/01.
  • Li L, Hsu HC, Grizzle WE, et al. Cellular mechanism of thymic involution. Scand J Immunol. 2003;57(5):410–22. Epub 2003/05/20.
  • Virts EL, Thoman ML. Age-associated changes in miRNA expression profiles in thymopoiesis. Mech Ageing Dev. 2010;131(11–12):743–8. Epub 2010/10/12.
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33. Epub 2009/01/27.
  • Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunol. 2008;9(4):405–14. Epub 2008/ 03/11.
  • Ventura A, Young AG, Winslow MM, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132(5):875–86. Epub 2008/ 03/11.
  • Ohyashiki M, Ohyashiki JH, Hirota A, et al. Age-related decrease of miRNA-92a levels in human CD8+ T-cells correlates with a reduction of naive T lymphocytes. Immun Ageing : I & A. 2011;8(1):11. Epub 2011/11/16.
  • Salaun B, Yamamoto T, Badran B, et al. Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Translational Med. 2011;9:44. Epub 2011/04/22.
  • Rosenberg C, Bovin NV, Bram LV, et al. Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccines Immunother. 2013;9(7):1466–76. Epub 2013/04/11.
  • Shin JI, Bayry J. An age-related decline of CD62L and vaccine response: A role of microRNA 92a? Human Vaccines Immunother. 2014;10(5):1404–1405. Epub 2014/01/10.
  • Li G, Yu M, Lee WW, et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012;18(10):1518–24. Epub 2012/10/02.
  • Bratic A, Larsson NG. The role of mitochondria in aging. J Clin Invest. 2013;123(3):951–7. Epub 2013/03/05.
  • Seeger T, Haffez F, Fischer A, et al. Immunosenescence-associated microRNAs in age and heart failure. Eur J Heart Fail. 2013;15(4):385–93. Epub 2012/12/22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.